Clarkston Capital Partners LLC Buys 377,652 Shares of Ralliant Corporation $RAL

Clarkston Capital Partners LLC boosted its stake in shares of Ralliant Corporation (NYSE:RAL) by 200.1% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 566,405 shares of the company’s stock after purchasing an additional 377,652 shares during the quarter. Clarkston Capital Partners LLC owned 0.50% of Ralliant worth $24,769,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently bought and sold shares of the stock. Envestnet Asset Management Inc. bought a new position in shares of Ralliant during the 2nd quarter worth about $4,922,000. Bank of New York Mellon Corp bought a new stake in shares of Ralliant in the second quarter valued at about $32,655,000. Resona Asset Management Co. Ltd. acquired a new stake in Ralliant during the second quarter worth about $1,582,000. SouthState Corp bought a new position in Ralliant during the second quarter valued at about $35,000. Finally, Savant Capital LLC bought a new position in Ralliant during the second quarter valued at about $410,000.

Analyst Ratings Changes

Several analysts have recently weighed in on the company. Royal Bank Of Canada decreased their price objective on Ralliant from $52.00 to $41.00 and set a “sector perform” rating on the stock in a report on Friday, February 6th. Oppenheimer decreased their price target on shares of Ralliant from $60.00 to $50.00 and set an “outperform” rating on the stock in a research note on Friday, February 6th. Barclays dropped their price objective on shares of Ralliant from $60.00 to $52.00 and set an “overweight” rating for the company in a research note on Monday, February 9th. Weiss Ratings downgraded shares of Ralliant from a “hold (c)” rating to a “sell (d)” rating in a report on Thursday, February 5th. Finally, Vertical Research upgraded shares of Ralliant from a “hold” rating to a “buy” rating and set a $45.00 target price on the stock in a research report on Friday, February 6th. Seven equities research analysts have rated the stock with a Buy rating, three have issued a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $50.50.

Ralliant Price Performance

Ralliant stock opened at $44.74 on Monday. The company has a debt-to-equity ratio of 0.38, a current ratio of 0.84 and a quick ratio of 0.58. The company has a market capitalization of $5.00 billion and a PE ratio of 22.83. Ralliant Corporation has a one year low of $37.27 and a one year high of $57.02. The business has a 50 day simple moving average of $48.94 and a 200 day simple moving average of $46.70.

Ralliant (NYSE:RAL) last announced its quarterly earnings results on Wednesday, February 4th. The company reported $0.69 EPS for the quarter, beating the consensus estimate of $0.67 by $0.02. The company had revenue of $554.60 million during the quarter, compared to analyst estimates of $543.04 million. The firm’s revenue for the quarter was up 1.2% on a year-over-year basis. Ralliant has set its Q1 2026 guidance at 0.460-0.520 EPS and its FY 2026 guidance at 2.220-2.420 EPS.

Ralliant Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, March 23rd. Stockholders of record on Monday, March 9th will be issued a $0.05 dividend. The ex-dividend date of this dividend is Monday, March 9th. This represents a $0.20 annualized dividend and a dividend yield of 0.4%. Ralliant’s dividend payout ratio is presently 10.20%.

Insider Buying and Selling at Ralliant

In other news, SVP Amir A. Kazmi acquired 2,545 shares of the firm’s stock in a transaction on Friday, February 6th. The shares were purchased at an average cost of $39.27 per share, with a total value of $99,942.15. Following the completion of the purchase, the senior vice president owned 39,699 shares of the company’s stock, valued at $1,558,979.73. This represents a 6.85% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Kate Mitchell acquired 2,350 shares of the company’s stock in a transaction dated Tuesday, February 10th. The shares were purchased at an average cost of $42.48 per share, with a total value of $99,828.00. Following the acquisition, the director owned 8,411 shares of the company’s stock, valued at approximately $357,299.28. This represents a 38.77% increase in their position. The disclosure for this purchase is available in the SEC filing. Insiders have acquired a total of 8,145 shares of company stock worth $332,233 over the last ninety days.

Ralliant Company Profile

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.